Balancing the Risks and Benefits of Benzodiazepines

Following a September 2020 FDA announcement of a boxed warning for benzodiazepines, this viewpoint reviews their relative benefits and risks to reduce overuse in at-risk patients, moderate underuse in clinically appropriate instances, and guide judicious, rational prescribing.

Journal of the American Medical Association